University of Vienna
Also known as: AKH University of Vienna | Department of Anesthesiology, University of Vienna Medical School, Vienna, Austria | Department of Psychiatry, University of Wien | General Hospital / University Hospital Vienna, Austria | Medical Universitiy of Vienna | Medical University of Vienna, Vienna General Hospital, Vienna, Austria | Medicinal University Vienna | MU Vienna | Prof. Dr. Dieter Willbold | University of Vienna | University of Vienna, Austria | University Of Vienna, Department of Cardiology | University of Vienna, Institute of Sport Science | University of Vienna Medical School AKH | Vienna General Hospital
Highest phase reached
Phase 4
First clinical trial
Jul 1, 1996Last known activity
Jan 1, 2025
Timeline
1360s
- Jan 1, 1365
University of Vienna— Founded
Drugs by trial phase (341 distinct, 341 trials)
Phase 4 (140 own, 0 via acquisition)
Phase 3 (52 own, 0 via acquisition)
Phase 2 (63 own, 0 via acquisition)
Phase 1 (27 own, 0 via acquisition)
Indications
Studied for
- Abscess
- Acidosis
- Acidosis, Lactic
- Acute Coronary Syndrome
- Acute Kidney Injury
- Acute Lung Injury
- Adenoma, Islet Cell
- Alcoholism
- Alzheimer Disease
- Anemia
- Anemia, Hemolytic
- Anemia, Hemolytic, Autoimmune
- Anemia, Iron-Deficiency
- Anxiety Disorders
- Aortic Valve Stenosis
- Apnea
- Arterial Occlusive Diseases
- Arthritis
- Arthritis, Rheumatoid
- Ascites
- Atherosclerosis
- Atrial Fibrillation
- Back Pain
- Beriberi
- Birth Weight
- Body Weight
- Bone Diseases
- Bone Diseases, Metabolic
- Brain Diseases
- Brain Injuries
- Breast Neoplasms
- Candidiasis
- Candidiasis, Vulvovaginal
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma in Situ
- Carcinoma, Non-Small-Cell Lung
- Cardiomyopathies
- Cardiomyopathy, Dilated
- Cardiovascular Diseases
- Cervical Intraepithelial Neoplasia
- Chikungunya Fever
- Cholecystolithiasis
- Cholelithiasis
- Cholestasis
- Choroidal Neovascularization
- Chronic Kidney Disease-Mineral and Bone Disorder
- Colitis
- Colitis, Ulcerative
- Colorectal Neoplasms
- Colorectal Neoplasms, Hereditary Nonpolyposis
- Coronary Artery Disease
- Coronary Disease
- Critical Illness
- Crohn Disease
- Cytomegalovirus Infections
- Deficiency Diseases
- Delayed Graft Function
- Demyelinating Diseases
- Depression
- Depressive Disorder
- Dermatitis
- Dermatitis, Atopic
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Diabetic Nephropathies
- Diabetic Retinopathy
- Disease
- Dry Eye Syndromes
- Dyslipidemias
- Eczema
- Edema
- Embolism
- Encephalitis
- Encephalitis, Japanese
- Encephalitis, Tick-Borne
- Endotoxemia
- Epistaxis
- Erectile Dysfunction
- Esophageal Neoplasms
- Eye Diseases
- Fatigue
- Fatty Liver
- Fever
- Fibrosis
- Fractures, Bone
- Gallstones
- Gender Dysphoria
- Glaucoma
- Glaucoma, Open-Angle
- Glucose Intolerance
- Graves Ophthalmopathy
- Heart Arrest
- Heart Defects, Congenital
- Heart Diseases
- Heart Failure
- Heart Valve Diseases
- Hemangiosarcoma
- Hemophilia A
Recent trials (50)
- NCT06527248Lead sponsorN/AJan 1, 2025
- NCT06527248OfficialN/AJan 1, 2025
- NCT06527248Sponsor investigatorN/AJan 1, 2025
- NCT06689761Lead sponsorN/ANov 13, 2024
- NCT06689761Sponsor investigatorN/ANov 13, 2024
- NCT06745102Sponsor investigatorN/AFeb 1, 2024
- NCT06745102Lead sponsorN/AFeb 1, 2024
- NCT06125054CollaboratorPhase 2Dec 31, 2023
- NCT06048718OfficialPhase 2Dec 31, 2023
- NCT06286657Lead sponsorN/AAug 1, 2023
- NCT06286657Sponsor investigatorN/AAug 1, 2023
- NCT06286644Sponsor investigatorN/AMay 30, 2022
- NCT06286644Lead sponsorN/AMay 30, 2022
- NCT05457400CollaboratorPhase 1Apr 28, 2022
- NCT05220371Lead sponsorN/AJan 28, 2022
Details
- Founded
- Vienna, AT Jan 1, 1365
- Last known activity
- Jan 1, 2025